Winslow Capital Management, LLC Eli Lilly & CO Transaction History

Winslow Capital Management, LLC

$27.4 Billion
Q3 2024

A detailed history of Winslow Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Winslow Capital Management, LLC holds 771,113 shares of LLY stock, worth $575 Million. This represents 2.49% of its overall portfolio holdings.

Number of Shares

771,113

Previous 603,157 27.85%

Holding current value

$575 Million

Previous $546 Million 25.1%

% of portfolio

2.49%

Previous 1.97%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $130 Million - $161 Million	167,956 Added 27.85%	771,113 $683 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $28.3 Million - $35.6 Million	39,109 Added 6.93%	603,157 $546 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $50.3 Million - $67.3 Million	-84,923 Reduced 13.09%	564,048 $439 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $1.1 Million - $1.3 Million	2,094 Added 0.32%	648,971 $378 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $70.2 Million - $96.8 Million	161,509 Added 33.28%	646,877 $347 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $170 Million - $228 Million	485,368 New	485,368 $228 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $319 Million - $413 Million	-1,942,514 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $54.5 Million - $72.2 Million	-417,948 Reduced 17.71%	1,942,514 $328 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $12.1 Million - $14 Million	-82,670 Reduced 3.38%	2,360,462 $349 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $102 Million - $122 Million	745,802 Added 43.94%	2,443,132 $401 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $202 Million - $250 Million	1,697,330 New	1,697,330 $235 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $193 Million - $225 Million	-1,741,194 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $30.3 Million - $35.6 Million	272,003 Added 18.51%	1,741,194 $226 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $156 Million - $174 Million	1,469,191 New	1,469,191 $170 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $11,733 - $13,466	-155 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $159 Million - $187 Million	-2,135,934 Reduced 99.99%	155 $12,000
Q4 2017 Feb 12, 2018	SELL	$81.94 - $87.89 $137 Million - $147 Million	-1,674,453 Reduced 43.94%	2,136,089 $180 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $294 Million - $326 Million	3,810,542	3,810,542 $326 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Capital Management, LLC with notifications on news.

Account

Winslow Capital Management, LLC Eli Lilly & CO Transaction History